MDI 0151
Alternative Names: MDI-0151; MOD-ALatest Information Update: 28 Jun 2024
At a glance
- Originator Modulus Discovery
- Developer Alivexis
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Dipeptidyl peptidase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Inflammation